• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

77086-22-7 IC50

Background The cDNA-mediated Annealing, extension, Selection and Ligation (DASL) assay has

July 24, 2017 by Katherine Lewis Leave a Comment

Background The cDNA-mediated Annealing, extension, Selection and Ligation (DASL) assay has turned into a suitable gene expression profiling system for degraded RNA from paraffin-embedded tissue. oncogene homolog 2 (ERBB2) was the most differentially portrayed gene between your HER2 + and HER2 – tumors and seven extra genes acquired p-values < 0.05 and log2 -fold shifts ... [Read more…]

Posted in: Blogging Tagged: 77086-22-7 IC50, Mouse monoclonal to R-spondin1

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by